...
首页> 外文期刊>Archives of otolaryngology--head & neck surgery. >Long-term results of bilateral endoscopic vidian neurectomy in the management of moderate to severe persistent allergic rhinitis
【24h】

Long-term results of bilateral endoscopic vidian neurectomy in the management of moderate to severe persistent allergic rhinitis

机译:双侧内镜下玻璃体神经切除术治疗中重度持续性变应性鼻炎的长期结果

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: To evaluate the long-term efficacy of bilateral endoscopic vidian neurectomy in the management of moderate to severe persistent allergic rhinitis. Design: A prospective reassessment of the postoperative long-term results of bilateral endoscopic vidian neurectomy using the Rhinoconjunctivitis Quality of Life Questionnaire and visual analog scale for patients with moderate to severe persistent allergic rhinitis. Setting: University hospital. Patients: A total of 236 patients with moderate to severe persistent allergic rhinitis were divided into the following 3 treatment groups: those who underwent bilateral endoscopic vidian neurectomy (group 1, n=93), those who underwent partial inferior turbinectomy and/or septoplasty (group 2, n=51), and those who received conservative therapy (controls, n=92). Main Outcome Measure: The patients' quality of life was assessed at 6 months, 1 year, and 3 years after undergoing the initial selected treatments for moderate to severe persistent allergic rhinitis. The complications were observed after treatment. Results: Data from 199 of 236 patients who had complete follow-up documents were statistically analyzed. The average posttreatment bilateral endoscopic vidian neurectomy scores of the Rhinoconjunctivitis Quality of Life Questionnaire and visual analog scale were significantly improved at 6 months, 1 year, and 3 years compared with pretreatment scores for group 1 (P<.00) and for those in groups 2 and 3 during the same period. By the patient's self-evaluation posttreatment, the percentages of much improved, improved, and not improved was 64.7% (55 cases), 24.7% (21 cases), and 10.6% (9 cases), respectively. The percentages were significantly higher for those in group 1 than for those in group 2 (P<.05). No severe complication occurred in all 3 patient groups. Conclusion: In the hands of a well-trained surgeon bilateral endoscopic vidian neurectomy is an effective and safe technique in the management of moderate to severe persistent allergic rhinitis.
机译:目的:评价双侧内镜下静脉玻璃体神经切除术在中重度持续性变应性鼻炎治疗中的长期疗效。设计:使用鼻结膜炎生活质量问卷和视觉模拟量表对中度至重度持续性变应性鼻炎患者进行双侧内窥镜下玻璃体神经切除术的术后长期结果进行前瞻性评估。地点:大学医院。患者:总共236例中度至重度持续性变应性鼻炎患者分为以下3个治疗组:进行了双侧内镜下静脉玻璃体神经切除术的患者(第1组,n = 93),经历了部分下下路肾小管切开和/或隔膜成形术的患者(第2组,n = 51),以及接受保守治疗的患者(对照组,n = 92)。主要观察指标:在为中度至重度持续性过敏性鼻炎接受最初选择的治疗后的6个月,1年和3年,评估患者的生活质量。治疗后观察并发症。结果:对236例具有完整随访资料的患者中的199例进行了统计学分析。鼻结膜炎生活质量问卷和视觉模拟量表的治疗后双侧内窥镜下玻璃体神经切除术的平均得分在第1,6,3年比第1组和治疗组分别有显着改善(P <.00)。 2和3在同一时期。通过患者的自我评估后处理,有很大改善,改善和未改善的百分比分别为64.7%(55例),24.7%(21例)和10.6%(9例)。第1组的百分比显着高于第2组的百分比(P <.05)。所有3个患者组均未发生严重并发症。结论:在训练有素的外科医生手中进行双侧内镜静脉电子神经切除术是治疗中度至重度持续性变应性鼻炎的一种有效且安全的技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号